full free access: The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer

Abstract/full free access: Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada

excerpts of interest:

The C.A.M. Report » Blog

Note: This is a huge site with a vast amount of information including institutional based research etc.

National Center for Complimentary and Alternative Medicine

searchable database: eg. green tea oil, fish oil....

Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.

abstract (in research) HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in FT

"Our findings of immunoreactivity for HMGA2 may lead to a novel, useful biomarker to complement p53 in the detection of early-stage serous carcinoma."

abstract: Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004.

media item: In Research: OMRF identifies new method that may improve treatment of ovarian cancers

Who is OMRF?
"Founded in 1946, OMRF is one of the nation’s oldest and most respected nonprofit biomedical research institutes. Located in Oklahoma City, OMRF fosters a worldwide reputation for excellence by following an innovative cross-disciplinary approach to medical research."

Words that heal column by Deepak Chopra

Breaking down the breakthrough claims - Blog

Note: this one was all over the news this past week: partial excerpt: "A new drug called dabigatran prevents more strokes with less bleeding than warfarin." Dr. Atlas says: "Dabigatran may be a game changer, but there is one thing the story didn't mention. The group that got Dabigatran had more heart attacks than those who got coumadin. Oops! This could be the real game changer from the FDA's perspective. Note it's still under review there."

abstract: The treatment of menopausal symptoms by traditional East Asian medicines: Review and perspectives

Note: abstract provides very limited information

Coping with Cancer, Side Effects, Caregiving, and other Cancer Resources OncoLink (general)

news item: Ovarian Cancer Therapy Researchers at University of Tokyo target ovarian cancer therapy

AMA news: Participatory medicine: A high-tech alliance with patients

"At its most basic level, participatory medicine means shared decision-making and deep patient engagement. Because of the rise in technology use -- as well as an increase in out-of-pocket health care expenses -- this has gone well beyond the traditional tell-me-where-it-hurts conversation between patient and doctor in the exam room....Physicians "are afraid this is something that will cost them time and money, and it will create arguments with patients," Dr. Greene said."

abstract: Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors (1994–2003)

"The prognostic impact of BMI on survival was only noted for underweight patients with serous tumors."